Market Overview

Steve Sosnick's Valeant Options Trade

Related VRX
The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs
Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs
FDA rejects Valeant's application for psoriasis lotion Duobrii; shares down 5% premarket (Seeking Alpha)

Steve Sosnick of Interactive Brokers suggested on Bloomberg Markets an options strategy in Valeant Pharmaceuticals Intl Inc (NYSE: VRX).

The company is going to report earnings next week and Sosnick wants to use elevated implied volatility to sell options. He wants to sell the May 11, 17.50 strike call and buy the May 11, 19 strike call for a total credit of 60 cents.

If the stock drops below $17.50, Sosnick can maximally make 60 cents. The breakeven for the trade is at $18.10 and if the stock moves above that price, Sosnick is going to lose money. His maximal loss is 90 cents.

Posted-In: Interactive Brokers Steve SosnickOptions Markets Media


Related Articles (VRX)

View Comments and Join the Discussion!